"10.1371_journal.pone.0114519","plos one","2014-12-22T00:00:00Z","Benoit J Arsenault; Philip Barter; David A DeMicco; Weihang Bao; Gregory M Preston; John C LaRosa; Scott M Grundy; Prakash Deedwania; Heiner Greten; Nanette K Wenger; James Shepherd; David D Waters; John J P Kastelein; the Treating to New Targets (TNT) Investigators","Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; The Heart Research Institute, Sydney, Australia; Pfizer Inc, New York, NY, United States of America; State University of New York Health Science Center, Brooklyn, NY, United States of America; University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Veterans Affairs Central California Health Care System and University of California San Francisco School of Medicine, San Francisco, CA, United States of America; Universit√§tsklinikum, Eppendorf, Germany; Emory University School of Medicine, Atlanta, GA, United States of America; University of Glasgow, Glasgow, United Kingdom; San Francisco General Hospital, San Francisco, CA, United States of America","Conceived and designed the experiments: BJA PB DAD JCL SMG HG NKW JS DDW JJPK. Performed the experiments: GMP. Analyzed the data: BJA DAD WB JJPK. Wrote the paper: BJA JJPK. Study concept and design: PB DAD JCL SMG HG NKW JS DDW JJPK. Critical revision of the manuscript for important intellectual content: PB DAD JCL SMG PD HG NKW JS DDW.","This study was funded by Pfizer Inc. Dr. Arsenault has received consulting fees/honoraria from Pfizer Inc. Dr. Barter has received consulting fees/honoraria from AstraZeneca, Roche, Pfizer Inc., Abbott, and Merck. Drs. DeMicco, Bao and Preston are employees of Pfizer. Dr. LaRosa has received consulting fees from Amgen. Dr. Grundy has received consultant fees/honoraria from Merck and Co. Inc., and Pfizer Inc. Dr. Deedwania has worked as a consultant/advisor for Pfizer, Amgen, and AstraZeneca, and has received a speakers bureau from Pfizer and AstraZeneca. Dr. Greten has received consulting fees/honoraria from Merck, Kowa, and Pfizer. Dr. Wenger has received research grants from Merck, Pfizer Inc., Abbott, Gilead Sciences, and NHLBI and is a consultant/advisory board member of Abbot, Amgen, AstraZeneca, Janssen Pharmaceuticals, Merck, Pfizer Inc., and Gilead Sciences. Dr. Shepherd has received consulting fees from AstraZeneca, GlaxoSmithKline, Merck, Oxford Biosensors, Pfizer, Nicox, Roche, and Schering-Plough, and lecture fees from AstraZeneca, Merck, Abbott, Schering-Plough and Pfizer. Dr. Waters has received consulting fees/honoraria from Pfizer Inc., Servier, Roche, and Cerenis and other financial benefit from Merck/Schering Plough and BioSante. Dr. Kastelein has received lecture fees from Pfizer. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","12","Benoit J Arsenault","BJA",14,TRUE,10,1,4,2,TRUE,TRUE,TRUE,1,"14",TRUE
